The innovations will open up the cut fruit market, cut food waste, unlock new export markets, and reduce shipping costs, claims Tropic.

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

Dicerna Pharma has enticed another big pharma to partner its RNA interference platform, attracting a $200 million upfront deal with Roche for a drug to treat hepatitis B virus infections.

Danish drugmaker Novo Nordisk must like what it has seen in its two-year-old alliance with gene-silencing specialist ... since 2019 to develop multiple RNA interference (RNAi) candidates for ...

A new discovery offers hope for Huntington’s disease. This discovery provides hope that a DNA repair process may help slow or ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, researchers have identified a vulnerability that opens ...

Researchers have successfully disrupted the hepatitis B virus's ability to infect human liver cells in the laboratory using a ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.